Radioimmunotherapy with Anticea Antibodies in Mtc

Juweid, Malik E.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Small Research Grants (R03)
• Project #: 5R03CA066906-02
• Application #: 2110425
• Study Section: Cancer Clinical Investigation Review Committee (CCI)
• Project Start: 1995-04-01
• Project End: 1997-03-31
• Budget Start: 1996-04-01
• Budget End: 1997-03-31
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: Center for Molecular Medicine/Immunology
• City: Belleville
• State: NJ
• Country: United States
• Zip Code: 07950

Publications

Juweid, M E; Hajjar, G; Swayne, L C et al. (1999) Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma. Cancer 85:1828-42

Juweid, M; Sharkey, R M; Swayne, L C et al. (1997) Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled anticarcinoembryonic antigen antibodies. Surgery 122:1156-65

Goldenberg, D M; Juweid, M; Dunn, R M et al. (1997) Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy. J Nucl Med Technol 25:18-23; quiz 34

Juweid, M; Sharkey, R M; Behr, T et al. (1996) Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. J Nucl Med 37:905-11

Juweid, M; Sharkey, R M; Behr, T et al. (1996) Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J Clin Oncol 14:1209-17

Juweid, M; Sharkey, R M; Behr, T et al. (1995) Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res 55:5946s-5951s